We are live on
!
Find out more
AC
Athos Capital Portfolio holdings
AUM
$324M
1-Year Est. Return
16.62%
This Fund
S&P 500
This Quarter
Est. Return
+11.14%
1 Year Est. Return
+16.62%
3 Year Est. Return
+82.15%
5 Year Est. Return
+203.21%
10 Year Est. Return
–
AUM
$146M
AUM Growth
+$2.22M
(+1.5%)
Cap. Flow
-$2.43M
Cap. Flow
% of AUM
-1.66%
Top 10 Holdings %
Top 10 Hldgs %
90.4%
Holding
32
New
13
Increased
5
Reduced
3
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WUBA
58.com Inc
WUBA
|
+$33.4M |
| 2 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$27.5M |
| 3 |
JD.com
JD
|
+$8.45M |
| 4 |
CZR
Caesars Entertainment Corporation
CZR
|
+$5.82M |
| 5 |
Alibaba
BABA
|
+$5.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$50.6M |
| 2 |
BHP
BHP
|
+$17.5M |
| 3 |
T-Mobile US
TMUS
|
+$8.61M |
| 4 |
CY
Cypress Semiconductor
CY
|
+$7.7M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$6.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.45% |
| 2 | Healthcare | 6.55% |
| 3 | Technology | 3.82% |
| 4 | Financials | 3.67% |
| 5 | Utilities | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WUBA
1
DELISTED
58.com Inc
WUBA
| $35M | 23.87% |
+648,046
| New | +$33.4M |
|
|
CBPO
2
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $27.6M | 18.83% |
269,832
+256,932
| +1,992% | +$27.5M |
|
|
TIF
3
DELISTED
Tiffany & Co.
TIF
| $21.5M | 14.69% |
176,406
+11,100
| +7% | +$1.39M |
|
|
4
JD.com
JD
$44.6B
| $10M | 6.86% |
+166,858
| New | +$8.45M |
|
|
BBL
5
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $8.88M | 6.06% |
215,750
-67,379
| -24% | -$2.45M |
|
|
WMGI
6
DELISTED
Wright Medical Group Inc
WMGI
| $8.52M | 5.82% |
286,524
+18,600
| +7% | +$544K |
|
|
CZR
7
DELISTED
Caesars Entertainment Corporation
CZR
| $6.99M | 4.77% |
+576,022
| New | +$5.82M |
|
|
8
Alibaba
BABA
$293B
| $5.41M | 3.69% |
+25,081
| New | +$5.22M |
|
9
Sony
SONY
$137B
| $4.98M | 3.4% |
360,000
+154,500
| +75% | +$2.01M |
|
10
HSBC
HSBC
$365B
| $3.51M | 2.4% |
150,504
+110,101
| +273% | +$2.73M |
|
11
Evergy
EVRG
$19.1B
| $2.37M | 1.62% |
+40,000
| New | +$2.37M |
|
|
TCO
12
DELISTED
Taubman Centers Inc.
TCO
| $2.34M | 1.6% |
+62,000
| New | +$2.53M |
|
|
CHL
13
DELISTED
China Mobile Limited
CHL
| $2.18M | 1.49% |
+64,900
| New | +$2.4M |
|
14
Toyota
TM
$224B
| $1.65M | 1.13% |
+13,143
| New | +$1.63M |
|
15
NetEase
NTES
$85.3B
| $1.61M | 1.1% |
+18,740
| New | +$1.41M |
|
16
Sumitomo Mitsui Financial
SMFG
$164B
| $1.12M | 0.77% |
+200,000
| New | +$1.08M |
|
17
Takeda Pharmaceutical
TAK
$54.6B
| $1.08M | 0.73% |
+60,000
| New | +$1.08M |
|
18
Genworth Financial
GNW
$3.76B
| $741K | 0.51% |
+320,800
| New | +$1.01M |
|
|
GSUM
19
DELISTED
Gridsum Holding Inc.
GSUM
| $616K | 0.42% |
879,192
-11,600
| -1% | -$8.43K |
|
|
CETV
20
DELISTED
Central European Media Enterprises Ltd
CETV
| $176K | 0.12% |
+49,725
| New | +$184K |
|
|
BMY.RT
21
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $173K | 0.12% |
48,283
-221,800
| -82% | -$800K |
|
|
22
BHP
BHP
$215B
| – | – |
-534,260
| Closed | -$17.5M |
|
23
KT
KT
$8.62B
| – | – |
-78,000
| Closed | -$607K |
|
|
24
T-Mobile US
TMUS
$185B
| – | – |
-102,600
| Closed | -$8.61M |
|
25
CALL
Xerox
XRX
$386M
| – | – |
-100,000
| Closed | -$1.89M |
|
Similar funds
THCM
WG
FAL
AIA
DMC
KL
UOC
MFA
Athos Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Athos Capital held 32 positions worth $146M, up 1.5% from $144M the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Athos Capital's Q2 2020 filing shows 13 new, 5 increased, 3 reduced and 11 closed positions. Its largest new stake was 58.com Inc: 648,046 shares worth $35M. The largest sale was Allergan plc, an estimated $50.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 0% a quarter earlier, followed by Healthcare and Technology.
- Athos Capital's largest Q2 2020 buy was 58.com Inc: 648,046 shares worth $35M.
- Athos Capital added most to China Biologic Products Holdings, Inc. in Q2 2020, an estimated $27.5M increase.
- Athos Capital's biggest Q2 2020 reduction was BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares), cutting an estimated $2.45M.
- Athos Capital fully exited Allergan plc in Q2 2020, selling an estimated $50.6M.
- Athos Capital's ten largest holdings make up 90% of its $146M portfolio in Q2 2020.
- Athos Capital opened 13 new positions and closed 11 in Q2 2020.
- Athos Capital's portfolio value rose 1.5% quarter-over-quarter to $146M.
Based on Athos Capital's 13F filing for Q2 2020, filed 13 Aug 2020.